SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MCAR
MCAR 0.0650-36.3%Jan 31 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Walter Monroe who wrote (320)4/25/1998 7:09:00 PM
From: zgoodman   of 467
 
I talked to the Company about competition and the answer I got was sensible:

1) They expect competition
2) They haven't seen anything significant come up in the way of competition (This makes sense, because I can't find anyone doing this either)
3) Competition will likely raise the profile of alternative incontinence treatment
4) Because this is still a relatively untapped market, competition would probably help the company rather than hurt it.

Does this sound like good PR? Absolutely. But is also makes sense.

Please stop taking pot-shots at MCAR and posters to this thread: Instead, do the right thing and come back with answers to HARD questions, just as Mr. Dewalt suggested earlier.

Regards,

Goodman

PS: In the mean time, you can always sell your stock if you don't like the company.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News